LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China · Delayed Price · Currency is CNY 11.82
-0.02 (-0.17%)
Jun 18, 2026, 3:00 PM CST
SHA:603883 Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, SHA:603883 stock has a consensus rating of "Buy" and an average price target of ¥18.60. The average 1-year stock price forecast is 57.36% higher than the current stock price, while the lowest is ¥14.00 (+18.44%) and the highest is ¥25.66 (+117.09%).
Price Target: ¥18.60 (+57.36%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:603883 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 4 | 4 | 4 | 5 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 2 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 12 | 12 | 12 | 13 |
Financial Forecast
Revenue This Year
23.77B
from 22.24B
Increased by 6.92%
Revenue Next Year
25.83B
from 23.77B
Increased by 8.63%
EPS This Year
1.08
from 0.46
Increased by 133.80%
EPS Next Year
1.34
from 1.08
Increased by 24.59%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 25.7B | ||
| Avg | 23.8B | ||
| Low | 22.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.4% | ||
| Avg | 6.9% | ||
| Low | 2.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.08 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 133.8% | ||
| Low | - |